The company says its deal with IsleChem is a part of its strategy for long-term growth. By adding manufacturing expertise in the US, Aceto boosts its global supply network that is mainly focused in India and China. Agreements like these, CEO Gilles Cottier said, have become increasingly important amid the coronavirus crisis.
“The Covid pandemic has reinforced that access to a diverse, secure supply chain and dependable manufacturing is essential to business continuity,” he said. “This acquisition adds manufacturing and R&D capabilities to enhance Aceto’s already robust supply network. IsleChem is poised for facility expansion to service growing market demand, allowing the combined company to support more of our customers’ needs, from development through to commercialization and full-scale production.”
The post Aceto adds chemical supply presence in the US appeared first on Pharmaceutical Commerce.